Louisiana Purchase: State Eager To Test “Netflix Model” For Rx Spending
Executive Summary
A subscription payment model could be a solution for high-priced drugs, Louisiana thinks – and appears to have at least one manufacturer willing to participate. Will the Trump Administration agree?
You may also be interested in...
Louisiana ‘Netflix’ Model For Hepatitis C Drugs Caps Spending At $35m Per Year
Purchasing contract for state Medicaid and Corrections programs would last up to five years and aim to treat more than 10,000 patients in first year.
Pivot To Video? “Netflix” Rx Pricing Model Plays Well With Media
A subscription model for drug pricing isn’t an entirely new idea, but it is a timely one. If nothing else, the idea of a “Netflix” approach appeals to media savvy audiences.
Gilead’s Price Reduction Strategy: A Serious Move, But Not A Long-Term Model For US
“Authorized generics” for Gilead's leading hepatitis C brands stands out from prior, largely symbolic responses to the lower list prices. This is not a political move, but a business one. It is also the clearest demonstration yet of why pricing reforms are necessary if lower list prices are the policy goal.